Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Aug;78(8):5104-8.
doi: 10.1073/pnas.78.8.5104.

Increased susceptibility to cytomegalovirus infection in beige mutant mice

Increased susceptibility to cytomegalovirus infection in beige mutant mice

G R Shellam et al. Proc Natl Acad Sci U S A. 1981 Aug.

Abstract

Mice homozygous for the beige gene (bg/bg) are a homologue of the Chédiak-Higashi syndrome of man and are known to be selectively defective in natural killer (NK) cells. We have compared the susceptibility of bg/bg and bg/+ C57BL/6J mice to infection with murine cytomegalovirus (MCMV). Beige mice are more susceptible to lethal infection and develop 33- to 43-fold higher virus titers in the liver, spleen, and kidney than do bg/+ mice after a sublethal infection, although virus replication is the same in vitro in cultured fibroblasts or epithelial cells from these mice. Inoculation with a sublethal dose of virus stimulates a NK cell response, although this is lower in bg/bg mice despite higher titers of interferon type 1 than in bg/+. A dose of MCMV that is lethal only to bg/bg augments cytotoxicity within 12 hr in bg/+ mice, whereas cytotoxicity in bg/bg remains very low. In bone marrow chimeras, recipients of bg/bg marrow were more susceptible to MCMV and had lower NK cell responses after virus inoculation than did recipients of marrow from bg/+ donors. The greater susceptibility of beige mice to the virus suggests that NK cells may contribute to resistance early in McMV infection.

PubMed Disclaimer

References

    1. Transplantation. 1973 May;15(5):526-30 - PubMed
    1. Adv Cancer Res. 1978;27:305-77 - PubMed
    1. J Exp Med. 1976 Feb 1;143(2):450-5 - PubMed
    1. J Immunol. 1976 May;116(5):1459-65 - PubMed
    1. Infect Immun. 1977 Aug;17(2):458-62 - PubMed

Publication types